Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.

Domínguez A, Castilla J, Godoy P, Delgado-Rodríguez M, Saez M, Soldevila N, Astray J, Mayoral JM, Martín V, Quintana JM, González-Candelas F, Galán JC, Tamames S, Castro A, Baricot M, Garín O, Pumarola T; CIBERESP Cases and Controls in Pandemic Influenza Working Group (Spain).

Hum Vaccin Immunother. 2013 Apr;9(4):865-73. doi: 10.4161/hv.23090. Epub 2013 Apr 1.

2.

Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD.

Thornton Snider J, Luna Y, Wong KS, Zhang J, Chen SS, Gless PJ, Goldman DP.

Curr Med Res Opin. 2012 Dec;28(12):1959-67. doi: 10.1185/03007995.2012.743459. Epub 2012 Nov 27.

PMID:
23098081
3.

Immunization disparities by Hispanic ethnicity and language preference.

Haviland AM, Elliott MN, Hambarsoomian K, Lurie N.

Arch Intern Med. 2011 Jan 24;171(2):158-65. doi: 10.1001/archinternmed.2010.499.

PMID:
21263106
4.

Understanding the reasons for the underuse of pneumococcal vaccination by community-dwelling older African Americans.

Jones LG, Zhang Y, Ahmed MI, Ekundayo OJ, Akhter S, Sawyer P, Aban I, Sims RV, Ahmed A.

J Am Geriatr Soc. 2010 Dec;58(12):2323-8. doi: 10.1111/j.1532-5415.2010.03181.x.

5.

[Vaccination against pneumococcal infection in adults].

Viejo JL.

Rev Esp Quimioter. 2009 Nov;22 Suppl 1:26-8. Review. Spanish. No abstract available.

6.

Effects of pneumococcal vaccination on hospitalization and exacerbations in elderly Japanese chronic obstructive pulmonary disease patients.

Yamaya M, Fujino N, Kubo H, Arai H.

Geriatr Gerontol Int. 2009 Jun;9(2):206-9. doi: 10.1111/j.1447-0594.2008.00496.x. No abstract available.

PMID:
19490143
7.

[Economic aspects of hospitaly treated pneumococcal pneumonia and the results of Pneumo 23 vaccine use in Serbia].

Adzić T, Rosić I, Jovanović D, Medić-Stojanac S.

Srp Arh Celok Lek. 2008 Nov-Dec;136(11-12):625-8. Serbian.

PMID:
19177825
8.

Increasing pneumococcal vaccination in managed care through telephone outreach.

Winston CA, Mims AD, Leatherwood KA.

Am J Manag Care. 2007 Oct;13(10):581-8.

9.

Cost benefits of targeting the pneumococcal vaccination program to the elderly population in Taiwan.

Chen YH, Yang GY, Loh CH, Liou SH, Su WL, Lin SH, Chou CC.

Am J Infect Control. 2006 Nov;34(9):597-9.

PMID:
17097456
10.

Lack of ethnic disparities in adult immunization rates among underserved older patients in an urban public health system.

Appel A, Everhart R, Mehler PS, MacKenzie TD.

Med Care. 2006 Nov;44(11):1054-8.

PMID:
17063138
11.

Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up.

Vila-Córcoles A, Ochoa-Gondar O, Ester F, Sarrá N, Ansa X, Saún N; EVAN Study Group.

BMC Public Health. 2006 Sep 18;6:231.

12.
13.

Community-acquired pneumonia in the elderly.

Kaplan V, Angus DC.

Crit Care Clin. 2003 Oct;19(4):729-48.

PMID:
14601717
14.

Reduction of the influenza burden in children.

Committee on Infectious Diseases. American Academy of Pediatrics.

Pediatrics. 2002 Dec;110(6):1246-52. Review.

PMID:
12456926
15.

The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease.

Nichol KL, Baken L, Wuorenma J, Nelson A.

Arch Intern Med. 1999 Nov 8;159(20):2437-42.

PMID:
10665892
16.

Pneumococcal vaccine: clinical efficacy and effectiveness.

Schwartz JS.

Ann Intern Med. 1982 Feb;96(2):208-20. Review.

PMID:
6800290
17.

A cost-benefit analysis of immunization for pneumococcal pneumonia.

Patrick KM, Woolley FR.

JAMA. 1981 Feb 6;245(5):473-7.

PMID:
6779017
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk